Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2013

01.03.2013 | General Gynecology

The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience

verfasst von: Omer Demirtas, Levent Akman, Gulsah Selvi Demirtas, Behiye Seda Hursitoglu, Huseyin Yilmaz

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare patients with tubo ovarian abscess (TOA) and non-TOA acute pelvic inflammatory disease (PID) and to determinate admitted day laboratory cut-off values for the TOA.

Materials and methods

Files of inpatients admitted to our clinic with the diagnoses of PID and/or TOA between the years of 2006 and 2011. Laboratory and culture results were obtained from the database of hospital. A total of 73 patients diagnosed with PID and/or TOA were evaluated. Patients who were diagnosed with TOA and PID by physical and sonographic examination were assigned to group 1 and group 2, respectively. Both groups were compared in terms of laboratory, clinical, and epidemiological parameters.

Results

Of 73 patients admitted with the diagnosis of PID, 44 (60.3 %) were found to have TOA, and 29 (39.7 %) were not found. Mean age of patients was determined as 41.4 ± 7.7 in group 1 and as 35.1 ± 6.8 in group 2. Abscess was detected more frequently in patients with low socio-cultural level, and this was found to be statistically significant. The diameter of abscess was found to be ≥5 cm in 39 (88.6 %) patients and <5 cm in 5 (11.4 %) patients. The average length of hospital stay was statistically significantly increased in patients with an abscess of ≥5 cm in size compared to patients with an abscess of <5 cm. When C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), leukocyte counts were statistically evaluated by ROC curves, diagnostic ability of CRP, ESR and leukocyte count was found to be 73, 87, and 58 %. CRP has a specificity of 63 % and a sensitivity of 72 % if cut-off value is considered as 11.5 mg/L whereas ESR has a specificity of 83 % and a sensitivity of 79 % if cut-off value is considered as 19.5 mm/1/2 h.

Conclusion

ESR >19.5 mm/1/2 h and CRP >11.5 mg/L were the best predictors of TOA. The high level of CRP and ESR was associated with longer duration of hospitalization and disease severity, and these levels were statistically significantly associated with TOA size of ≥5 cm.
Literatur
1.
Zurück zum Zitat Granberg S, Gjelland K, Ekerhovd E (2009) The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 23:667–678PubMedCrossRef Granberg S, Gjelland K, Ekerhovd E (2009) The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 23:667–678PubMedCrossRef
2.
Zurück zum Zitat Pedowitz P, Bloomfield RD (1964) Rüptured adnexal abscess (tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 88:721–729PubMed Pedowitz P, Bloomfield RD (1964) Rüptured adnexal abscess (tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 88:721–729PubMed
3.
Zurück zum Zitat Vermeeren J, Te Linde RW (1954) Intraabdominal rupture of pelvic abscesses. Am J Obstet Gynecol 68:402–409PubMed Vermeeren J, Te Linde RW (1954) Intraabdominal rupture of pelvic abscesses. Am J Obstet Gynecol 68:402–409PubMed
4.
Zurück zum Zitat Rosen M, Breitkopf D, Waud K (2009) Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 64:681–689PubMedCrossRef Rosen M, Breitkopf D, Waud K (2009) Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 64:681–689PubMedCrossRef
5.
Zurück zum Zitat Paik CK, Waetjen LE, Xing G, Dai J, Sweet RL (2006) Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstet Gynecol 107:611–616PubMedCrossRef Paik CK, Waetjen LE, Xing G, Dai J, Sweet RL (2006) Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstet Gynecol 107:611–616PubMedCrossRef
6.
Zurück zum Zitat Wiesenfeld HC, Sweet RL (1993) Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 36:433–644PubMedCrossRef Wiesenfeld HC, Sweet RL (1993) Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 36:433–644PubMedCrossRef
7.
Zurück zum Zitat Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL et al (2002) Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol 186:929–937PubMedCrossRef Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL et al (2002) Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol 186:929–937PubMedCrossRef
8.
Zurück zum Zitat Hager WD, Eschenbach DA, Spence MR, Sweet RL (1983) Criteria for diagnosing and grading of salpingitis. Obstet Gynecol 61:113–114PubMed Hager WD, Eschenbach DA, Spence MR, Sweet RL (1983) Criteria for diagnosing and grading of salpingitis. Obstet Gynecol 61:113–114PubMed
9.
Zurück zum Zitat Fleischer AC, Entman SS (1975) Differential diagnosis of pelvic masses. In: Chervenak FA, Isaacson GC, Campbell S (eds) Ultrasound in obstetrics and gynecology. Little Brown, Boston, p 1650 Fleischer AC, Entman SS (1975) Differential diagnosis of pelvic masses. In: Chervenak FA, Isaacson GC, Campbell S (eds) Ultrasound in obstetrics and gynecology. Little Brown, Boston, p 1650
10.
Zurück zum Zitat Uhrich PC, Sanders RC (1976) Ultrasonic characteristics of pelvic inflammatory masses. J Clin Ultrasound 4:199–204PubMedCrossRef Uhrich PC, Sanders RC (1976) Ultrasonic characteristics of pelvic inflammatory masses. J Clin Ultrasound 4:199–204PubMedCrossRef
11.
Zurück zum Zitat Franklin EW, Hevron JE Jr, Thompson JD (1973) Management of the pelvic abscess. Clin Obstet Gynecol 16:66–79PubMedCrossRef Franklin EW, Hevron JE Jr, Thompson JD (1973) Management of the pelvic abscess. Clin Obstet Gynecol 16:66–79PubMedCrossRef
12.
Zurück zum Zitat Ginsburg DS, Stern JL, Hamod KA et al (1980) Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 138:1055–1058PubMed Ginsburg DS, Stern JL, Hamod KA et al (1980) Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 138:1055–1058PubMed
13.
Zurück zum Zitat DeWitt J, Reining A, Allsworth EJ, Peipert FJ (2010) Tuboovarian abscesses: ıs size associated with duration of hospitalization and complications? Obstetr Gynecol Int 2010:847041 DeWitt J, Reining A, Allsworth EJ, Peipert FJ (2010) Tuboovarian abscesses: ıs size associated with duration of hospitalization and complications? Obstetr Gynecol Int 2010:847041
14.
Zurück zum Zitat Reed SD, Landers DV, Sweet RL (1991) Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 164:1556–1562PubMed Reed SD, Landers DV, Sweet RL (1991) Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 164:1556–1562PubMed
15.
Zurück zum Zitat Chang CC, Wang PH, Su PH, Lin DB, Ying TH, Yang SF, Hsieh YH (2011) Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease. Clin Chem Lab Med 49:1655–1660PubMedCrossRef Chang CC, Wang PH, Su PH, Lin DB, Ying TH, Yang SF, Hsieh YH (2011) Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease. Clin Chem Lab Med 49:1655–1660PubMedCrossRef
16.
Zurück zum Zitat Wang PH, Liu YF, Tsai HT, Tee YT, Lin LY, Hsieh YH, Yang SF (2010) Elevated plasma osteopontin level is associated with pelvic inflammatory disease. Reprod Sci 17:1052–1058PubMedCrossRef Wang PH, Liu YF, Tsai HT, Tee YT, Lin LY, Hsieh YH, Yang SF (2010) Elevated plasma osteopontin level is associated with pelvic inflammatory disease. Reprod Sci 17:1052–1058PubMedCrossRef
17.
Zurück zum Zitat Lee SH, Lin CY, Wang PH, Han CP, Yang SF, Chang JT, Lee MC, Lin LY, Lee MS (2012) Significant association of elevated concentration of plasma YKL-40 with disease severity in patients with pelvic inflammatory disease. J Clin Lab Anal 26:136–142PubMedCrossRef Lee SH, Lin CY, Wang PH, Han CP, Yang SF, Chang JT, Lee MC, Lin LY, Lee MS (2012) Significant association of elevated concentration of plasma YKL-40 with disease severity in patients with pelvic inflammatory disease. J Clin Lab Anal 26:136–142PubMedCrossRef
18.
Zurück zum Zitat Miettinen AK, Heinonen PK, Laippala P, Paavonen J (1993) Test performance of erythrocyte sedimentation rate and C- reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 169:1143–1149PubMed Miettinen AK, Heinonen PK, Laippala P, Paavonen J (1993) Test performance of erythrocyte sedimentation rate and C- reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 169:1143–1149PubMed
19.
Zurück zum Zitat Halperin R, Svirsky R, Vaknin Z, Ben-Ami I, Schneider D, Pansky M (2008) Predictors of tuboovarian abscess in acute pelvic inflammatory disease. J Reprod Med 53:40–44PubMed Halperin R, Svirsky R, Vaknin Z, Ben-Ami I, Schneider D, Pansky M (2008) Predictors of tuboovarian abscess in acute pelvic inflammatory disease. J Reprod Med 53:40–44PubMed
20.
Zurück zum Zitat Paik CK, Waetjen LE, Xing G, Dai J, Sweet RI (2006) Hospitalizations for pelvic inflamatory disease and tuboovarian abscess. Obstet Gynecol 107:611–616PubMedCrossRef Paik CK, Waetjen LE, Xing G, Dai J, Sweet RI (2006) Hospitalizations for pelvic inflamatory disease and tuboovarian abscess. Obstet Gynecol 107:611–616PubMedCrossRef
21.
Zurück zum Zitat Geissdörfer W, Böhmer C, Pelz K, Schoerner C, Frobenius W, Bogdan C (2003) Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery. J Clin Microbiol 41:2788–2790PubMedCrossRef Geissdörfer W, Böhmer C, Pelz K, Schoerner C, Frobenius W, Bogdan C (2003) Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery. J Clin Microbiol 41:2788–2790PubMedCrossRef
22.
Zurück zum Zitat McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940–943PubMedCrossRef McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940–943PubMedCrossRef
23.
Zurück zum Zitat Sweet RL (2006) Tubo-ovarian abscess in pelvic ınflammatory disease. Taylor and Francis, London, pp 101–124 Sweet RL (2006) Tubo-ovarian abscess in pelvic ınflammatory disease. Taylor and Francis, London, pp 101–124
Metadaten
Titel
The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience
verfasst von
Omer Demirtas
Levent Akman
Gulsah Selvi Demirtas
Behiye Seda Hursitoglu
Huseyin Yilmaz
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2600-3

Weitere Artikel der Ausgabe 3/2013

Archives of Gynecology and Obstetrics 3/2013 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.